SpyGlass Pharma, Inc. (SGP) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-26 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-09 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-02-13 | 8-K | Officer / Director Changes | SEC |
| 2026-02-09 | 8-K | Officer / Director Changes, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.